A banner reportedly spotted inside ChatGPT and posted on November 6 invites businesses to 'Claim your business in ChatGPT,' alongside an analytics view counting how often a business appears in responses. Analyst Juozas Kaziukenas posted the screenshot; he reports the tool measures impressions and clicks daily, and the banner carries a red 'unreleased/beta' label and fine print saying you will need to verify you are authorised to represent the business.

The banner's three cards cover tracking how often your business is mentioned in ChatGPT conversations, adding products and keeping business details current, and letting a business agent answer customer questions with context you control. Kaziukenas calls it part of a larger Business Hub he says he first saw steps of in August, and says it does not show prompts, user data or competitor benchmarks.

OpenAI has confirmed none of it. Search Engine Roundtable, Search Engine Land and RuntimeWire all covered the same single screenshot the same morning, and checks of OpenAI's small-business announcement, business page and release notes found no mention of claiming, analytics or mention tracking. This stays rumor, unresolved.

Update, November 9: Digiday added two unnamed sources with knowledge of the tool and reported that OpenAI is testing the dashboard inside a wider Business Hub that has not launched yet, plotting daily impressions and clicks, still with no prompts, user data or competitor rankings shown. OpenAI declined to comment. Digiday also reported that OpenAI claimed a $1 billion annualised ChatGPT ads run rate by September. The dashboard remains a test, not a launch, so this stays rumor, unresolved.

Update, November 10: Confirmed. Reuters reported that OpenAI launched "Businesses" in beta within ChatGPT, with Business Hub for claiming and managing a profile, aggregated mentions/views/clicks insights, and Business Agents rolling out first to eligible US e-commerce and online service businesses. See the November 10 Businesses launch entry. This rumor is now confirmed.